Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons

Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy

(2014) Joell J. Gills et al.   Autophagy

Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003

(2013) Pragna Patel et al.   ANNALS OF INTERNAL MEDICINE

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes

(2011) J. Bohlius et al.   BLOOD

HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

(2011) M. J. Silverberg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998–2008

(2011) Mathias Bruyand et al.   JOURNAL OF HEPATOLOGY

Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

(2010) Joanne Reekie et al.   CANCER

Reduced Risk of Prostate Cancer in U.S. Men with AIDS

(2010) M. S. Shiels et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

(2010) M. C. F. Prosperi et al.   CLINICAL INFECTIOUS DISEASES

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

(2009) Jerry Polesel et al.   AIDS

HIV infection and the risk of cancers with and without a known infectious cause

(2009) Michael J Silverberg et al.   AIDS

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authorsʼ reply

(2009) Nancy F Crum-Cianflone et al.   AIDS

Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV‐Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort

(2009) Mathias Bruyand et al.   CLINICAL INFECTIOUS DISEASES

Cancer risk in HIV-infected persons: influence of CD4+count

(2009) Gary M Clifford et al.   Future Oncology

Illustrating bias due to conditioning on a collider

(2009) Stephen R Cole et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

(2009) Marguerite Guiguet et al.   LANCET ONCOLOGY

Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo

(2009) Matteo Landriscina et al.   PROSTATE

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

(2008)   AIDS

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

(2008) Christophe Piketty et al.   AIDS

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

(2008) Nancy Crum-Cianflone et al.   AIDS

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

(2008) S Franceschi et al.   BRITISH JOURNAL OF CANCER

Cancer risk in people infected with human immunodeficiency virus in the United States

(2008) Eric A. Engels et al.   INTERNATIONAL JOURNAL OF CANCER

Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

(2008) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

(2008) Thomas Powles et al.   JOURNAL OF CLINICAL ONCOLOGY

Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era

(2008) Roger Bedimo   Current HIV/AIDS Reports